Study to evaluate the safety and efficacy of tigilanol tiglate in the treatment of grey horse melanomas
Title: Safety and potential efficacy of 20% v/v tigilanol tiglate (0.2 mg/cm3 lesion volume) in the treatment of grey horse melanomas Investigators: Corey Saba, DVM, DACVIM (Oncology faculty) Jarred Williams, DVM, DACVS-LA (Equine faculty) If interested, please have your primary veterinarian request additional information through the UGA Oncology service by […]
Study to evaluate the safety and efficacy of tigilanol tiglate in the treatment of equine sarcoid tumors
Investigators: Corey Saba, DVM, DACVIM (Oncology faculty) Jarred Williams, DVM, DACVS-LA (Equine faculty) If interested, please have your primary veterinarian request additional information through the UGA Oncology service by calling the referral coordinator at 706-542-3221, or the Clinical Trials Coordinator Lisa Reno at 706-296-7818. Study description: The objectives of this […]
